Abstract: This disclosure pertains to methods and systems for selecting an end to end freight service. In one embodiment, the methods and systems disclosed herein allow for rapid and efficient selection of freight services for moving mass. In one embodiment, the methods and systems disclosed herein comprise normalizing freight service options.

Abstract: This disclosure pertains to systems and methods for managing supply chains. In one embodiment, the systems and methods disclosed herein comprise an automated system for maintaining an inventory of products. In one embodiment, the systems and methods disclosed herein optimize time and financial costs required for transporting mass via freight services.

Abstract: This disclosure pertains to methods and systems for organizing dispatch matters for managing the movement of mass. In one embodiment, the methods and systems disclosed herein comprise an aggregate of dispatch matters presented on a Physical, Tangible Display Means. In one embodiment, an exception event changes the arrangement of dispatch matters.

Abstract: This disclosure pertains to methods and systems for selecting an end to end freight service. In one embodiment, the methods and systems disclosed herein allow for rapid and efficient selection of freight services for moving mass. In one embodiment, the methods and systems disclosed herein comprise normalizing freight service options.

Abstract: This disclosure pertains to systems and methods for managing supply chains. In one embodiment, the systems and methods disclosed herein comprise an automated system for maintaining an inventory of products. In one embodiment, the systems and methods disclosed herein optimize time and financial costs required for transporting mass via freight services.

Abstract: Human mesenchymal stromal cells can be induced to differentiate into oligodendrocytes and neurons, respectively. For these cell types, therefore, MSCs can be a therapeutic source, either in vitro or in vivo, in the context of treating pathologies of the central nervous system which are characterized by neuron loss, such as Parkinson's disease, Alzheimer's disease and stroke, as well as head trauma, or by dysfunction in ganglioside storage or demyelinization, such as Tay-Sachs disease, G1 gangliosidosis, metachromatic leukodystrophy, and multiple sclerosis.